GENOVIS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 35.5 SEK | -2.61% |
|
-7.19% | -31.73% |
| 05-15 | Genovis AB (publ.) Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 03-14 | Carthesian Therapeutics Terminates Genovis AB (Publ.) Licence Agreement | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOVIS AB | Diagnostic & Testing Substances | -2.61% | -7.19% | -31.73% | -29.14% | +83.94% | 220M |  |  |  |
- Stock Market
- Equities
- GENO Stock
- Charts Genovis AB
- Relative Strength Chart
